Amgen Inc - ESG Rating & Company Profile powered by AI
The report of Amgen Inc was assembled by All Street Sevva using proprietary Cognitive Robots. Check the end of this webpage for potential risks for Amgen Inc based on industry, location and marketcap. This SDG score for Amgen Inc represents the company's reporting of the UN Sustainable Development Goals.
Amgen Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.7; made up of an environmental score of 6.0, social score of 6.0 and governance score of 8.0.
6.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 314 | Trulieve Cannabis Corp | 6.8 | High |
| 314 | Vicore Pharma Holding AB | 6.8 | High |
| 337 | Amgen Inc | 6.7 | High |
| 337 | Calyxt Inc | 6.7 | High |
| 337 | CanSino Biologics Inc | 6.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Amgen Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Amgen Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Amgen Inc report the average age of the workforce?
Sign up for free to unlockDoes Amgen Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Amgen Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Amgen Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Amgen Inc offer flexible work?
Sign up for free to unlockDoes Amgen Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Amgen Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Amgen Inc conduct supply chain audits?
Sign up for free to unlockDoes Amgen Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Amgen Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Amgen Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Amgen Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Amgen Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Amgen Inc disclose water use targets?
Sign up for free to unlockDoes Amgen Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Amgen Inc have a product recall in the last two years?
Sign up for free to unlockDoes Amgen Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Amgen Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Amgen Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Amgen Inc disclose parental leave metrics?
Sign up for free to unlockDoes Amgen Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Amgen Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Amgen Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Amgen Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Amgen Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Amgen Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Amgen Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Amgen Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Amgen Inc disclose its waste policy?
Sign up for free to unlockDoes Amgen Inc report according to TCFD requirements?
Sign up for free to unlockDoes Amgen Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Amgen Inc disclose energy use targets?
Sign up for free to unlockDoes Amgen Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Amgen Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Amgen Inc
These potential risks are based on the size, segment and geographies of the company.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.